Seno Medical Instruments

Company profile

About Seno Medical Instruments

Seno Medical Instruments is a medical imaging company that has developed the Imagio® Breast Imaging System, an innovative diagnostic platform that fuses opto-acoustic technology with gray-scale ultrasound to improve breast cancer detection and diagnosis. The company's flagship product addresses inefficiencies in the current breast cancer diagnostic pathway, which often results in multiple procedures, inconclusive results, and negative patient experiences. The Imagio® system uses laser light transmitted through suspicious breast tissue to generate ultrasound signals that display both functional and anatomical information about relative blood and oxygen concentration. This enables clinicians to differentiate between malignant and benign tissue in real-time with a single exam. The system is enhanced by SenoGram®, a native AI-based clinical decision support tool that assists radiologists in making more accurate diagnoses at the point of care. Seno Medical holds the core patent on opto-acoustic technology for medical applications and has developed a robust intellectual property portfolio. The company's technology aims to reduce the 71% false-positive biopsy rate, decrease the median 48-day wait time from abnormal mass detection to diagnosis, and eliminate unnecessary procedures. The Imagio® system has received FDA PMA approval in the United States and serves radiologists, healthcare systems, and patients by providing earlier diagnosis of malignancy, reducing patient stress and wait times, and improving practice efficiency. Beyond breast cancer, the company envisions future applications in thyroid, head and neck, prostate, cervical, ovarian, and bladder cancers, as well as therapeutic drug monitoring.

Company description · Seno Medical Instruments official website